Central Provident Fund (Medisave Account Withdrawals) (Amendment No. 3) Regulations 2002

Status:

Published in Subsidiary Legislation Supplement
on 01 Oct 2002

No. S 528

Central Provident Fund Act

(Chapter 36)

Central Provident Fund (Medisave Account Withdrawals) (Amendment No. 3) Regulations 2002

In exercise of the powers conferred by section 77(1)(j) of the Central Provident Fund Act, the Minister for Manpower, after consulting the Central Provident Fund Board, hereby makes the following Regulations:

Citation and commencement

1. These Regulations may be cited as the Central Provident Fund (Medisave Account Withdrawals) (Amendment No. 3) Regulations 2002 and shall come into operation on 1st October 2002.

Amendment of regulation 2

2. Regulation 2(1) of the Central Provident Fund (Medisave Account Withdrawals) Regulations 2001 (G.N. No. S 570/2001) (referred to in these Regulations as the principal Regulations) is amended —

(a)

by deleting the definition of “cancer chemotherapy treatment” and substituting the following definition:

“ “cancer chemotherapy treatment” means the treatment of neoplasms by chemotherapy;”;

(b)

by deleting the words “cancer chemotherapy” in the 1st and 2nd lines of the definition of “medical treatment” and substituting the words “treatment of neoplasms by chemotherapy”; and

(c)

by deleting the full-stop at the end of the definition of “treatment for sexual sterilization” and substituting a semi-colon, and by inserting immediately thereafter the following definition:

“ “treatment of neoplasms by chemotherapy” means the administration of tested and approved chemotherapeutic agents by the usual and known routes in the treatment of malignant and benign neoplasms, and neoplasms of uncertain behaviour.”.

Amendment of regulation 10

3. Regulation 10 (1) of the principal Regulations is amended by deleting sub-paragraphs (a) and (b) and substituting the following sub-paragraphs:

“(a)

the total charges in respect of the vaccination, subject to the following withdrawal limits:

Age of patient

Withdrawal limits (per course of treatment)

(i) below 12 years

$25

(ii) 12 to 19 years

$35

(iii) 20 years or above

$50;

(b)

in the case of an individual booster vaccination that is approved by the Minister for Health, the total charges in respect of the individual booster vaccination, subject to the following withdrawal limits:

Age of patient

Withdrawal limits

(i) below 12 years

$10

(ii) 12 to 19 years

$15

(iii) 20 years or above

$20; or”.

Amendment of regulation 12

4. Regulation 12 of the principal Regulations is amended —

(a)

by deleting the words “cancer chemotherapy treatment” in the 1st and 2nd lines of paragraph (2) and substituting the words “treatment of neoplasms by chemotherapy”; and

(b)

by deleting paragraph (4) and substituting the following paragraph:

“(4) No withdrawal shall be permitted under these Regulations for the payment of any charges in respect of any anti-retroviral drug or any drug for the purposes of treating opportunistic infection registered in Singapore for the medical treatment of human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), except where such treatment is for the member himself or his child aged 18 years or below.”.

Amendment of regulation 16

5. Regulation 16 (1) of the principal Regulations is amended —

(a)	by inserting, immediately after the word “member” in the 2nd line, the words “or his child aged 18 years or below”; and
(b)	by inserting, immediately after the words “per month” in sub-paragraphs (a), (b) and (c), the words “per patient”.

Amendment of Schedule

6. The Schedule to the principal Regulations is amended —

(a)

by deleting paragraph (b) of item 1 and substituting the following paragraph:

“

(b) Brachy-therapy with external radiotherapy

For course of treatment beginning before 1st June 1997

$150 per treatment or the total credit balance in the member’s medisave account, whichever is the lower.

For course of treatment beginning on or after 1st June 1997

$300 per treatment or the total credit balance in the member’s medisave account, whichever is the lower.

”;

(b)

by deleting item 3 and substituting the following item:

“

3. Treatment of neoplasms by chemotherapy

With effect from 1st October 2002

$1,200 per treatment cycle of 21 days or 28 days or $300 per weekly cycle or the total credit balance in the member’s medisave account, whichever is the lower.

”;

(c)

by inserting, immediately after the words “per month” in the third column of item 4, the words “per patient”; and

(d)

by inserting, immediately after item 7, the following items:

“

8. Intravenous antibiotic infusion at approved hospitals as designated by the Minister of Health

With effect from 1st October 2002

$600 per weekly cycle subject to a maximum claim of $2,400 per year or the total credit balance in the member’s medisave account, whichever is the lower.

9. Rental of devices for long term oxygen therapy and infant continuous positive airway pressure therapy

With effect from 1st October 2002

$75 per month or the total credit balance in the member’s medisave account, whichever is the lower.

10. Cyclosporin or tacrolimus drug for organ transplant

With effect from 1st October 2002

$300 per month or the total credit balance in the member’s medisave account, whichever is the lower.

”.

[G. N. Nos. S 679/2001; S 102/2002; S 319/2002]

Made this 1st day of September 2002.

TAN CHIN NAM

Permanent Secretary,
Ministry of Manpower,
Singapore.

[MM S10/82 V12; AG/LEG/SL/36/2002/2 Vol. 1]

(To be presented to Parliament under section 78(2) of the Central Provident Fund Act).

Search within Legislation